DEF 14AThe Ballot
Avalo Therapeutics, Inc. files DEF 14A
Filed Oct 19, 2023 · 2y ago · Accession 0001628280-23-034686
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Avalo Therapeutics, Inc.
- Ticker
- AVTX
- CIK
- 1534120
- Form type
- DEF 14A
- Filing date
- Oct 19, 2023
- Report date
- Dec 5, 2023
- Document
- def14a-2023a.htm
- Size
- 1.5 MB